Mohammad Reza Bigdeli

Dr. Mohammad Reza Bigdeli

Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran 193815476, Iran

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SKSeyedeh Mahdieh Khoshnazar
Seyedeh Mahdieh Khoshnazar
SPSiavash Parvardeh
Siavash Parvardeh
MBMohammad Reza Bigdeli
Mohammad Reza Bigdeli

11 January 2022 in Brain Research Bulletin
Verified
Journal Article
Closed access
SKSepideh Khaksar
Sepideh Khaksar
MBMohammad Reza Bigdeli
Mohammad Reza Bigdeli
ASArash Samiee
Arash Samiee
ZSZahra Shirazi-Zand
Zahra Shirazi-Zand

1 January 2010 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
FMFatemeh Mohagheghi
Fatemeh Mohagheghi
MBMohammad Reza Bigdeli
Mohammad Reza Bigdeli
BRBahram Rasoulian
Bahram Rasoulian
AZAli Asghar Zeinanloo
Ali Asghar Zeinanloo
AKAli Khoshbaten
Ali Khoshbaten
Recent studies suggest that dietary virgin olive oil (VOO) reduces hypoxia-reoxygenation injury in rat brain slices. We sought to extend these observations in anin vivostudy of rat cerebral ischemia-reperfusion injury. Four groups, each consisting of 18 Wistar rats, were studied. One group (control) received saline, while three treatment groups received oral VOO (0.25, 0.5, and 0.75 mL/kg/day, respectively). After 30 days, blood lipid profiles were determined, before a 60-min period of middle cerebral artery occlusion (MCAO). After 24-h reperfusion, neurological deficit scores, infarct volume, brain edema, and blood brain barrier permeability were each assessed in subgroups of six animals drawn from each main group. VOO reduced the LDL/HDL ratio in doses of 0.25, 0.5, and 0.75 mL/kg/day in comparison to the control group (p< 0.05), and offered cerebroprotection from ischemia-reperfusion. For controls vs. doses of 0.25 vs. 0.5 vs. 0.75 mL/kg/day, attenuated corrected infarct volumes were 207.82 ± 34.29 vs. 206.41 ± 26.23 vs. 124.21 ± 14.73 vs. 108.46 ± 31.63 mm3; brain water content of the infarcted hemisphere was 82 ±± 0.25 vs. 81.5 ± 0.56 vs. 80.5 ± 0.22 vs. 80.5 ± 0.34%; and blood brain barrier permeability of the infarcted hemisphere was 11.31 ± 2.67 vs. 9.21 ± 2.28 vs. 5.83 ± 1.6 vs. 4.43 ± 0.93 µg/g tissue (p< 0.05 for measures in doses 0.5 and 0.75 mL/kg/day vs. controls). Oral administration of VOO reduces infarct volume, brain edema, blood brain barrier permeability, and improves neurologic deficit scores after transient MCAO in rats.

5 September 2017 in Brain Injury
Verified
Journal Article
Closed access
SKSepideh Khaksar
Sepideh Khaksar
MBMohammad Reza Bigdeli
Mohammad Reza Bigdeli
Background: Stroke is a neurological disease, which, in addition to high mortality, imposes many financial and mental burdens on families and the society. The main objective of this study was to investigate the effect of cannabidiol (CBD) on one of the major inflammatory pathways in cerebral ischaemia. Method: Using stereotaxic surgery, the cannula was implanted into the right lateral ventricle of rats. CBD (50, 100, and 200 ng/rat; i.c.v.) was administrated for five consecutive days. After pretreatment, the rats were subjected to 60 min of right middle cerebral artery occlusion (MCAO). After 24 h, neurological deficits score, infarct volume, brain oedema, and blood–brain barrier (BBB) permeability in total, core, and penumbra areas were assessed. The expression of tumour necrosis factor alfa (TNF-α), tumour necrosis factor receptor 1 (TNFR1), and nuclear factor-kappa B (NF-кB) in the mentioned regions was also studied. Results: Administration of CBD (100 and 200 ng/rat) caused a significant reduction in infarction, brain oedema, and BBB permeability compared with the vehicle-received group. Down-regulation of TNF-α, TNFR1, and NF-кB expression was also observed by CBD. Conclusion: The results achieved in this study support the idea that CBD has a cerebroprotective effect (partly through suppression of TNF-α, TNFR1, and NF-кB) on ischaemic injury. ABBREVIATIONS: CBD, cannabidiol; ANOVA, analysis of variance; PVDF, polyvinylidene difluoride; SDS-PAGE, sodium dodecyl sulphate polyacrylamide gel electrophoresis; SEM, standard error of mean.


1 April 2017 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
MBMohammad Reza Bigdeli
Mohammad Reza Bigdeli
SKSepideh Khaksar
Sepideh Khaksar
BCN is the official Publication of Neuroscience Departments of Tehran University of Medical Sciences and Shahid Beheshti University of Medical Sciences. BCN is an international multidisciplinary journal that publishes editorials, original full‐length research articles, short communications, reviews, methodological papers, commentaries, perspectives and “news and reports” in the broad fields of developmental, molecular, cellular, systems, computational, behavioral, cognitive, and clinical neurosciences. Manuscripts submitted to BCN should describe novel results generated by experiments that were guided by clearly defined aims or hypotheses and should not have appeared or submitted to any other journals. BCN’s aim is to provide serious ties in interdisciplinary communication, accessibility to a broad readership internationally, effective peer review process, and independence from all possible non scientific interests. BCN also tries to empower national, regional and international collaborative networks in the field of neuroscience and to be the voice of the Iranian and regional neuroscience community in the world of neuroscientists. BCN is a new journal dedicated to neuroscience field which intends to become an indexed and cited peer reviewed journal and to meet its quality standards in near future. To achieve this aim, BCN asks for support from all Iranian Neuroscientists doing research around the word in submitting manuscripts in all aspects of neuroscience research. We need your comments and valuable inputs. We are also asking Iranian Neuroscientists who are principle investigators to nominate as reviewers and/or editors in the different areas of neuroscience in BCN.